CLINICAL TRIALS PROFILE FOR ULTRALENTE
✉ Email this page to a colleague
All Clinical Trials for ULTRALENTE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00222521 ↗ | Insulin Glargine Vs Standard Insulin Therapy | Completed | Moran, Antoinette, M.D. | Phase 3 | 2003-04-01 | This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin. |
NCT00222521 ↗ | Insulin Glargine Vs Standard Insulin Therapy | Completed | Sanofi | Phase 3 | 2003-04-01 | This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin. |
NCT00222521 ↗ | Insulin Glargine Vs Standard Insulin Therapy | Completed | University of Minnesota | Phase 3 | 2003-04-01 | This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin. |
NCT00222521 ↗ | Insulin Glargine Vs Standard Insulin Therapy | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 3 | 2003-04-01 | This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin. |
NCT00276393 ↗ | Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes | Completed | Mayo Clinic | Phase 4 | 2002-07-01 | Patients with type 1 diabetes trained in multiple daily insulin injection were treated with two diffferent kinds of long acting insulin preparations. The two insulin preparations were glargine and ultralente insulin. Patients were randomized to receive one of the two insulin preparations for the first 4 months followed by the second preparation for a further four months. Short acting insulin used was the same during both periods. We found that glargine insulin was better than ultralente insulin in our study. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ULTRALENTE
Condition Name
Clinical Trial Locations for ULTRALENTE
Trials by Country
Clinical Trial Progress for ULTRALENTE
Clinical Trial Phase
Clinical Trial Sponsors for ULTRALENTE
Sponsor Name